Indivior director granted 3,722 RSUs in Form 4

Indivior Pharmaceuticals, Inc. director Juliet Thompson reported a grant of 3,722 restricted stock units of common stock on January 26, 2026 at a price of $0 per share.

Rhea-AI Filing Summary

Indivior Pharmaceuticals, Inc. director Juliet Thompson reported a grant of 3,722 restricted stock units of common stock on January 26, 2026 at a price of $0 per share. After this award, she beneficially owns 7,572 shares directly, with an additional 5,775 shares held indirectly by her spouse. The RSUs vest on the day immediately before the first annual stockholders’ meeting following the grant date, subject to her continued service.

Insider Trade Summary

Grant/Award: 3,722 shares

Grant/Award 2 txns

Insider Thompson Juliet

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,722	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 7,572 shares (Direct); Common Stock — 5,775 shares (Indirect, By Spouse)

Footnotes (1)

1. F1. Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the first annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Indivior (INDV) report for Juliet Thompson?

Indivior reported director Juliet Thompson receiving 3,722 restricted stock units of common stock on January 26, 2026. The award was reported at a price of $0 per share and increases her directly held beneficial ownership to 7,572 shares.

How many Indivior (INDV) shares does Juliet Thompson own after this Form 4?

After the reported grant, Juliet Thompson beneficially owns 7,572 shares of Indivior common stock directly. The filing also shows an additional 5,775 shares of common stock held indirectly, identified as being owned by her spouse.

What are the terms of the 3,722 RSUs reported for Indivior (INDV)?

The 3,722 units are restricted stock units, each representing a right to receive one Indivior common share. They vest on the day immediately preceding the first annual stockholders’ meeting after the grant date, conditioned on Thompson’s continued service to the company.

What is the reported price for Juliet Thompson’s Indivior (INDV) RSU grant?

The Form 4 lists the 3,722 restricted stock units at a transaction price of $0 per share. This reflects a stock-based compensation award rather than an open-market purchase, consistent with typical equity compensation structures for company directors.

What indirect Indivior (INDV) holdings are disclosed for Juliet Thompson?

The filing discloses 5,775 shares of Indivior common stock held indirectly, described as “By Spouse.” These shares are reported as beneficially owned indirectly, separate from Thompson’s 7,572 shares of directly held common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/28/2026 - 04:07 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Thompson Juliet

(Last) (First) (Middle)

10710 MIDLOTHIAN TURNPIKE

SUITE 125

(Street)

NORTH CHESTERFIELD VA 23235

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Indivior Pharmaceuticals, Inc. [ INDV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/26/2026		A		3,722(1)	A	$0	7,572	D
Common Stock								5,775	I	By Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the first annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date.

Remarks:

	/s/ Jordan Saltzberg, Power of Attorney	01/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.